Tumor progression locus 2 (Tpl2) deficiency does not protect against obesity-induced metabolic disease.

por Graeme I Lancaster, Greg M Kowalski, Emma Estevez, Michael J Kraakman, George Grigoriadis, Mark A Febbraio, Steve Gerondakis, Ashish Banerjee
Publicado 2012

A selective inhibitor of ceramide synthase 1 reveals a novel role in fat metabolism

por Nigel Turner, Xin Ying Lim, Hamish D. Toop, Brenna Osborne, Amanda E. Brandon, Elysha N. Taylor, Corrine E. Fiveash, Hemna Govindaraju, Jonathan D. Teo, Holly P. McEwen, Timothy A. Couttas, Stephen M. Butler, Abhirup Das, Greg M. Kowalski, Clinton R. Bruce, Kyle L. Hoehn, Thomas Fath, Carsten Schmitz-Peiffer, Gregory J. Cooney, Magdalene K. Montgomery, Jonathan C. Morris, Anthony S. Don
Publicado 2018